Platelet Glycoprotein IIb/IIIa Inhibitors
- 16 July 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (3), 379-385
- https://doi.org/10.1161/01.cir.0000019581.22812.b2
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The way I see it: House officers need formal career developmentBMJ, 2002
- Randomized, Placebo-Controlled Trial of Titrated Intravenous Lamifiban for Acute Coronary SyndromesCirculation, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesisThe Journal of cell biology, 2001
- Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trialThe Lancet, 2001
- Myocardial ischemia and infarctionJournal of the American College of Cardiology, 2001
- Platelet-Leukocyte Cross Talk in Whole BloodArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Long-Term Treatment with a Platelet Glycoprotein-Receptor Antagonist after Percutaneous Coronary RevascularizationNew England Journal of Medicine, 2000
- A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable AnginaNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998